Pacific Biosciences of California, Inc. (PACB)
2.33
+0.03
(+1.30%)
USD |
NASDAQ |
Oct 09, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Free Cash Flow : -130.48M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -130.48M |
| March 31, 2026 | -121.21M |
| December 31, 2025 | -118.92M |
| September 30, 2025 | -131.26M |
| June 30, 2025 | -157.32M |
| March 31, 2025 | -183.13M |
| December 31, 2024 | -212.25M |
| September 30, 2024 | -239.61M |
| June 30, 2024 | -261.44M |
| March 31, 2024 | -256.54M |
| December 31, 2023 | -275.39M |
| September 30, 2023 | -281.41M |
| June 30, 2023 | -282.15M |
| March 31, 2023 | -295.88M |
| December 31, 2022 | -280.14M |
| September 30, 2022 | -249.04M |
| June 30, 2022 | -223.57M |
| March 31, 2022 | -176.27M |
| December 31, 2021 | -117.11M |
| September 30, 2021 | -96.89M |
| June 30, 2021 | -73.46M |
| March 31, 2021 | -80.29M |
| December 31, 2020 | 18.46M |
| September 30, 2020 | 14.47M |
| June 30, 2020 | 14.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.66M |
| December 31, 2019 | -81.15M |
| September 30, 2019 | -81.87M |
| June 30, 2019 | -78.05M |
| March 31, 2019 | -75.73M |
| December 31, 2018 | -68.28M |
| September 30, 2018 | -70.50M |
| June 30, 2018 | -77.32M |
| March 31, 2018 | -77.73M |
| December 31, 2017 | -77.95M |
| September 30, 2017 | -72.24M |
| June 30, 2017 | -69.32M |
| March 31, 2017 | -74.75M |
| December 31, 2016 | -76.14M |
| September 30, 2016 | -62.18M |
| June 30, 2016 | -60.23M |
| March 31, 2016 | -46.99M |
| December 31, 2015 | -50.90M |
| September 30, 2015 | -65.14M |
| June 30, 2015 | -55.34M |
| March 31, 2015 | -60.97M |
| December 31, 2014 | -53.08M |
| September 30, 2014 | -51.92M |
| June 30, 2014 | -27.00M |
| March 31, 2014 | -29.60M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Illumina, Inc. | 511.00M |
| Danaher Corp. | 5.466B |
| Thermo Fisher Scientific, Inc. | 7.318B |
| Agilent Technologies, Inc. | 1.267B |
| Bio-Rad Laboratories, Inc. | 353.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.58M |
| Cash from Investing (Quarterly) | 40.07M |
| Cash from Financing (Quarterly) | 0.255M |
| Free Cash Flow Per Share (Quarterly) | -0.1262 |
| Free Cash Flow to Equity (Quarterly) | -41.93M |
| Free Cash Flow to Firm (Quarterly) | -37.08M |
| Free Cash Flow Yield | -18.37% |